Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RNAi in functional genomics.

Michaela Scherr1, Matthias Eder

  • 1Hannover Medical School, Department of Hematology and Oncology, Carl-Neuberg Strasse 1, D-30623 Hanover, Germany. M.Scherr@t-online.de

Current Opinion in Molecular Therapeutics
|June 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT.

Bone marrow transplantation·2026
Same author

A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

Bone marrow transplantation·2026
Same author

Combining inotuzumab ozogamicin with the p38 inhibitor BIRB 796 and venetoclax exerts synergistic cytotoxicity in B-cell precursor acute lymphoblastic leukemia including very high risk t(17;19) acute lymphoblastic leukemia.

Haematologica·2026
Same author

Serotonin 5-HT7 receptor signaling modulates inflammatory responses and survival after myocardial infarction.

Journal of translational medicine·2026
Same author

Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study.

Leukemia·2026
Same author

First-in-human EphA2-targeting PET imaging with the bicyclic radiotracer [<sup>68</sup>Ga]Ga-BCY18469 in pancreatic cancer patients: biodistribution, dosimetry and initial findings.

European journal of nuclear medicine and molecular imaging·2026

RNA interference (RNAi) offers a powerful strategy for analyzing mammalian gene function through stable gene silencing. Further research into RNAi mechanisms will optimize its use as a genetic tool, overcoming current limitations.

Area of Science:

  • Molecular Biology
  • Genetics
  • Mammalian Cell Biology

Background:

  • Systematic analysis of mammalian gene function has historically lacked powerful tools.
  • RNA interference (RNAi) presents a promising strategy for gene function studies.
  • Stable, heritable gene silencing in mammalian cells can be achieved via viral gene transfer of RNAi triggers.

Purpose of the Study:

  • To explore the potential of RNA interference (RNAi) as a tool for systematic mammalian gene function analysis.
  • To identify challenges and opportunities for optimizing RNAi as a genetic tool.

Main Methods:

  • Stable transcription of RNAi triggers from expression cassettes integrated into the host cell genome.
  • Utilizing viral gene transfer for delivery of RNAi triggers.

Related Experiment Videos

  • Leveraging recent insights into siRNA and miRNA-mediated silencing mechanisms.

    • Main Results:

    • RNAi can induce long-term and heritable gene silencing in mammalian cells.
    • Current limitations include identifying efficient RNAi triggers, effective delivery, off-target effects, and potential genotoxicity from viral vectors.

    Conclusions:

    • RNAi holds significant promise as a genetic tool for mammalian gene function analysis.
    • Understanding the molecular mechanisms of RNAi is crucial for optimizing its efficiency and safety.
    • Further development is needed to overcome delivery, specificity, and safety challenges for widespread application.